Evidence-based clinical practice guideline for management of immune checkpoint inhibitor-related cutaneous adverse events, developed through systematic review and Delphi consensus of international experts.
Keywords: Immunotherapy, Cutaneous Adverse Events, Clinical Guideline, Checkpoint Inhibitors, Dermatologic Oncology
Evidence-based clinical practice guideline for management of immune checkpoint inhibitor-related cutaneous adverse events, developed through systematic review and Delphi consensus of international experts.
This article is published open access by AAMS Dermatology & Cosmetology. The complete peer-reviewed text can be read on the journal page.
ResearchBib record · Crossref · Google Scholar